Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
4 May 18, 2020 FORM 4 SUBMISSION
SC 13D/A May 15, 2020 SC 13D/A
4 May 14, 2020 4
8-K May 14, 2020 8-K
4 Apr 17, 2020 4
SC 13D/A Apr 17, 2020 SC 13D/A
EFFECT Apr 14, 2020
424B4 Apr 14, 2020 424B4
POS EX Apr 14, 2020 POS EX
S-1MEF Apr 14, 2020 S-1MEF
CORRESP Apr 10, 2020
CORRESP Apr 10, 2020
S-1 Apr 10, 2020 S-1
424B3 Apr 10, 2020 424B3
EFFECT Apr 9, 2020
SC 13G/A Apr 9, 2020
UPLOAD Apr 8, 2020
CORRESP Apr 8, 2020
← Newer Page 21 of 26 · 646 filings Older →